James A. D. Smith is an experienced biotech and pharmaceutical executive and entrepreneur.  He served as CEO of Matrix Biomed, CEO/director of Virolab and President/CEO and a director of Genelabs Technologies, now a wholly owned division of GlaxoSmithKline.  Jim started his career at ICN Pharmaceuticals (now Bausch Health) where he served in a variety of executive capacities including Director of worldwide business development. Jim has been directly involved in development of novel drugs, generating more than $5 billion in revenue.